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Abstract
Background: This paper describes the development of a new quality of life instrument in advanced
cancer patients receiving palliative care.
Methods: The Palliative Care Quality of Life Instrument incorporates six multi-item and one
single-item scale. The questionnaire was completed at baseline and one-week after. The final
sample consisted of 120 patients.
Results: The average time required to complete the questionnaire, in both time points, was
approximately 8 minutes. All multi-item scales met the minimal standards for reliability (Cronbach's
alpha coefficient ≥.70) either before or during palliative treatment. Test-retest reliability in terms
of Spearman-rho coefficient was also satisfactory (p < 0.05). Validity was demonstrated by inter-
item correlations, comparisons with ECOG performance status, factor analysis, criterion-related
validation, and correlations with the Assessment of Quality of Life in Palliative Care Instrument
(AQEL), and the European Organisation for Research and Treatment of Cancer (EORTC) Core
Quality of Life Questionnaire (QLQ-C30, version 3.0).
Conclusion: The PQLI is a reliable and valid measure for the assessment of quality of life in
patients with advanced stage cancer.
Background
Recently, the health care community has recognised the
importance of using QoL measurement as an essential
component of a treatment modality's efficacy [1]. At every
stage of disease, treatment choices may involve modalities
that differ in side effects and impact upon QoL. Compre-
hensive, yet efficient, questionnaires are needed to meas-
ure QoL in cancer patients. Quality-of-life assessment can
be helpful in weighting the risks and benefits of treatment
options, particularly when differences in survival among
the options are small or non-existent [2].
Quality of life is subjective in nature, therefore there is a
wide agreement that health-related quality of life should
be conceptualised as a multidimensional construct [3].
Physical functioning, disease-and treatment-related symp-
toms, psychological/emotional well being, and social
interactions are critical domains that are included in most
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efforts to measure overall quality of life. When consider-
ing quality of life in advanced cancer patients one of the
treatment choices is a palliative one, therefore we consider
of great importance the inclusion of a new dimension
when measuring quality of life in such a population, that
of "choice of treatment". Recent studies and new articles
clearly indicate that physicians must be educated to rou-
tinely ask patients about their wishes for medical care and
to recognise that they are legally and morally bound to
honour those requests [4]. Such communication is espe-
cially pressing in the context of advanced illness, when the
achievement of a peaceful death assumes priority over
inappropriate prolongation of dying.
Many valid assessment instruments have been developed
that measure QoL such as EORTC [5], The Functional
Assessment of Cancer Treatment (FACT) [6]. In 1986, the
European Organisation for Research and Treatment initi-
ated a research program to develop an integrated, modu-
lar approach for evaluating the quality of life of patients
participating in international clinical trials [7]. EORTC
with its clinical focus and its multicultural orientation
provides a rather unique context for developing and test-
ing quality of life questionnaires [8].
The aim of our study was to assess the psychometric prop-
erties of a new quality of life instrument on a Hellenic
sample of terminally ill cancer patients receiving only pal-
liative treatment, which is called PQLI (Palliative Care
Quality of Life Instrument). It was found to be concise,
quantitative and easily used; it has been designed prima-
rily for use by the patients themselves; it was based on the
existing literature [7,9-11] and the items that the patients
consider as most important to what they perceive as
"quality of life", the latter was elicited by means of quali-
tative research. It became evident from the qualitative
assessment on the patients' description on their QoL that
there is a need to participate in the treatment process; this
would give them a sense of control over their fatal disease
[12]. Patients want a voice in their end-of-life care, and
participation in treatment choices encompasses the psy-
chosocial outcomes that these may have in their lives [13].
When considering quality of life in advanced cancer
patients the treatment choice is a palliative one, therefore
we consider of importance the inclusion of a new dimen-
sion when measuring quality of life in such a population,
that of "choice of treatment". The lack of a questionnaire
that examines the quality of life specifically in a palliative
care setting, the individuals that form their support sys-
tem, as well as the unique needs that these patients have,
was the driving force for a measurement like this to be
developed.
Methods
Patients with symptomatic incurable cancer disease were
selected for study by means of palliative treatment modal-
ity. No restrictions were placed with regard to histologic
type of cancer, age, or performance status. All patients
attended the "Pain Relief and Palliative Care Unit" of
Areteion Hospital where the study took place, between
January 2002 and October 2002. Criteria for inclusion
were: age > 18 years, no cerebral metastases, no known
psychiatric disorder, to be cognitively capable of filling in
the questionnaire, fluent in the Hellenic language, and off
anticancer treatment for ≥3 months. From 630 cancer and
non-cancer patients that were treated in the unit that
period, 144 advanced cancer patients were drawn using
stratified random sampling, according to the performance
status, and were judged eligible to enter the study. From
them, 24 patients (16.7%) were excluded due to refusal to
participate in the study. The hospital's ethics committee
also approved the study. The final sample was consecutive
and consisted of 120 responding patients from whom
written informed consent was obtained. The demograph-
ical data of the sample is shown in table 1.
Instrument development and procedures
The PQLI is a 28-item questionnaire, composed of six
multi-item scales (2 functional scales, 1 symptom scale, 1
choice of treatment scale, 1 psychological scale) and a sin-
gle item scale (overall quality of life). Each scale was
accompanied by a title. The questionnaire development
involved the following phases: first, literature search that
identified the relevant QoL issues, and the existing ques-
tionnaires, second, a provisional list of items was pre-
sented to 3 experts for feedback on appropriateness of
content and breadth of coverage, third, the list was admin-
istered to patients from the target group to determine the
extent to which they have experienced these problems,
while they were asked to choose a number of issues that
troubled them the most (Figure 1). Next, the resulting list
of items was reviewed for clarity and overlap by other
experts, and finally, the questionnaire was pretested by
administering it to some patients (N = 20) from the target
population, and through structured interviews with each
patient individually after the completion of the question-
naire. In these interviews, the patients rated the question-
naire scales within a range of "1" (i.e. first choice) to "7"
(i.e. seventh choice). The researchers, then, evaluated
whether scores from the resulting PQLI corresponded well
with those independently obtained ratings [14].
In the final questionnaire format six of the scales were pre-
sented into three optional statements to be scored 1, 2 and
3 respectively. In "Choice of Treatment" scale the patients
were asked to choose the item that is "most" important in
the choice of treatment and rate it 1; then choose the item
that is "next" important and rate it 2; and so on, the lastHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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item which is the "least"  important, the patients were
asked to rate it as 5. The single item scale "Overall Quality
of Life" has the form of a Bi-Polar Numerical scale.
The patients were asked to complete the questionnaire
twice, with 1-week interval. This rather short interval was
chosen because of the imminent risk of sudden changes in
their health status. The questionnaires were collected
immediately after completion. The instrument was
designed primarily to be a self-assessment but where the
patient's condition would not permit it the researcher
assisted him/her.
{In the Appendix - see additional file 1] is presented the
questionnaire in the English language. Two independent
translators translated the PQLI in English and then
another two independent translators translated it back to
Greek. A matching of these translations was then con-
ducted. The same translation method has already been
used in the validity and reliability of the EORTC QLQ C-
30 (v.3) in Greek [8].
Statistical Analysis
A range of analyses was carried out to establish scale reli-
ability, and to evaluate empirically the validity of the
questionnaire scales. The average of the items that con-
tribute to the scale is estimated. Higher mean scores from
0 to 100 represent a better level of functioning and QoL
on the scales of "Activity", "Self-care", "Support", "Com-
munication", "Psychological Affect", and "Overall Quality
of Life", and higher mean values on the health status scale,
represent more symptomatology and worse quality of life
[7]. The current procedures for scoring the PQLI reflect the
multidimensionality of the quality of life domain.
Table 1: Demographic and clinical data of sample
Mean age 61.17 (range:19–88)
Male to female ratio 58/62
N(%)
Marital status
Married or living with partner 74(62%)
Widowed but living with their children 43(36%)
Illiterate 3(2%)
Education
Elementary school 40(30%)
High school 42(35%)
University 38(32%)
Types of cancer
Lung 32(27%)
Gastrointestinal 25(21%)
Breast 17(14%)
Urinary track 14(12%)
Prostate 10(8%)
Head and neck 4(3%)
Multiple myeloma 2(2%)
Bone-Sarcoma 2(2%)
Soft tissue sarcoma 2(2%)
Glioblastoma Multiform 2(2%)
Astrocyttoma 2(2%)
Non-Hodgkin Lymphoma 2(2%)
Melanoma 2(2%)
Cervical uteri 2(2%)
Vulva 1(1%)
Vagina 1(1%)
ECOG status
0-
1-
2 39(32%)
3 81(68%)Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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Internal consistency
internal consistency of the questionnaire before and dur-
ing palliative treatment was assessed by Cronbach's alpha
and was considered acceptable for group comparisons if
the coefficient exceeded 0.70, as recommended by Nun-
nally [15]. Cronbach's alpha tests whether the items in a
questionnaire have a homogeneous content with respect
to the construct of interest.
Reliability
Test-retest reliability of patients' (N = 120) responses was
evaluated by comparing the scores recorded on two occa-
sions, an average of seven days apart (Spearman-rho test
[16]). The patient's clinical stage did not change between
the first and the second completion, and the status of the
patients was stable between test and retest. Due to its hier-
archical nature, the intertest reliability of the ranking
statements (Choice of Treatment) was established by
using the "Kendall's-W" test [15].
Validity
Five indirect methods to evaluate validity were adopted:
First, by comparing the scale scores with patients with
poorer and better Eastern Cooperative Oncology Group
(ECOG-the clinical variable assessed) [5] performance
status using the Mann-Whitney U non-parametric test
[15]. Second, by assessing the statistical difference of the
questionnaire-scales before and during treatment in terms
of Wilcoxon rank test between scales for related subjects.
Third, by Exploratory factor analysis, using principal com-
ponents with non-orthogonal (direct oblimin) rotation
[17], was used to assess the validity of the PQLI. As a
fourth process, correlations were calculated between PQLI
items and those of two others instruments, the Assess-
ment of Quality of Life in Palliative Care (AQEL) [18], and
the European Organisation for Research and Treatment of
Cancer (EORTC) Core Quality of Life Questionnaire
(QLQ-C30, version 3.0) [5]. The AQEL is focusing in
patients undergoing palliative treatment, includes 22
Variables, which -according to patients -affect their Quality of Life. Figure 1
Variables, which -according to patients -affect their Quality of Life.
82.50
65.83
84.16
70.83
98.30
87.50
80.80
02 0 4 0 6 0 8 0 100 %
Activity
Self care
 Health
Choice of treatment
Support
Communication
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items in seven scales, from physical, psychological, social
and existential domains, while it has proven to be reliable
and valid. In addition, the EORTC QLQ-C30 is a widely
used second-generation questionnaire designed to meas-
ure cancer patients' physical, psychological and social
functions. It is a psychometrically established 30-item
questionnaire, incorporated in nine multi-item, and sev-
eral single-item scales [19].
Finally, criterion-related validation was also conducted.
At first step, concurrent related validity was performed
with correlations among the scales of PQLI (inter-scale
correlations). Accordingly, the seven factors obtained
from the interview from the 120 patients were rated and
coded from 1 to 7 according to the patients' choice: 1st,
2nd, 3rd, 4th to 7th choice. The closeness of the hypothetical
model of PQLI to the empirical data of interviewing rating
scores is evaluated statistically through gamma test [20].
To evaluate whether scores from the PQLI instrument cor-
responded well with those independently obtained rat-
ings, we first performed a factor analysis in which the
seven latent variables from the PQLI form were intercorre-
lated with the seven forms from the interview. We then
tested a predictive model to observe whether constructs
from the PQLI instrument could predict analogous meas-
ured constructs from the interview measurements. Ini-
tially, all possible predictive paths were included
simultaneously and non-significant paths were dropped
gradually. This procedure was a test of both the conver-
gent and discriminative validity of the PQLI instrument
(i.e., variables on the PQLI should be related to corre-
sponding variables on the interview and not to non-corre-
sponding variables) and the criterion-related validity of
the PQLI form (i.e., the ability of the PQLI to predict an
independent criterion variable).
The whole statistical analysis was conducted using the
SPSS version 8.0 statistical package (SPSS Inc, Chicago,
IL).
Results
The 28 items were all acceptable to the participants. They
encompassed physical, social, health, and psychological
aspects of life. Each item exhibited distributions reflecting
sensitivity to variations in the attributes measured. Only 3
patients (2.5%) needed assistance because they were illit-
erate. The 61.7% of the participants regarded as most
important the variable of long-term quality of life, while
the 76.7% of the respondents regarded as least important
the variable "effects on sexual life". The distributions of
the respondents in each category, for example, were
51.7% of the respondents are not working, a 40% can
fully care for themselves, a 66.7% reported pain, 66.7% of
the patients reported support from their friends and rela-
tives, the 64.2% stated that they do not discuss their fam-
ily problems with their doctor, and a 49.2% answered that
they do not feel fear of death. From this figure the clinical
profile of patients can be seen. Although restricted to a
limited cultural setting, this data was considered quite
interesting for clinicians.
Descriptive statistics and scale reliability (multitrait scaling 
analysis)
The reliability of the PQLI with the approach of internal
consistency was evaluated. Internal consistency was calcu-
lated by Cronbach's standardised item alpha. Table 2
shows the means and standard deviations for the multi-
item measures, before and during treatment. From the
descriptive statistics matrix, the Cronbach's alpha for each
scale was found to be greater than the critical value of
0.70, while the overall Cronbach's alpha was 0.787. The
test-retest reliability (Table 3) of scales and items as well
showed that all the coefficients of agreement were greater
than 0.82 (P < 0.001 in all cases). Due to the nature of the
"Choice of Treatment" scale the reliability was calculated
by performing the Kendall's Coefficient of Concordance
and was found 0.353 with a P-value < 0.0001.
Validity
The correlation matrix of the scales within the PQLI-pre-
and-on-treatment is displayed in Table 4. The agreements
are strong, consistent and statistically significant at the
0.005 or 0.001 levels. As expected, the strongest correla-
tions were observed between the "Activity", "Self-care",
"Health Status", and "Choice of Treatment". However,
they also correlated highly to "Psychological Affect". The
"Overall Quality of Life" (OQoL), correlated substantially
with "Activity", "Health Status", "Self-care", "Choice of
Treatment", "Communication", "Support", and "Psycho-
logical Affect".
Factor analysis
Exploratory non-orthogonal factor analysis (Principal
Axis Factoring extraction with Direct Oblimin rotation)
was carried out to further explore the validity of the PQLI
instrument. The correlations between the variables are
high. The Bartlett Test of Sphericity was 3042.7 and it was
significant (p < 0.0001). The Kaiser-Meyer-Olkin Measure
of Sampling Adequacy was equal to 0.81 showing that the
data is suitable for factor analysis. Principal axis factoring
extraction was used to analyse the underlying structure of
the questionnaire, yielding seven independent factors
accounting for 79.7 % of the variance. This seven-factor
solution was deemed appropriate by examining the mag-
nitude and rate of change in eigenvalues. Based on the
rule that meaningful factors should be associated with
eigenvalues greater than 1.0 and a marginal change occur
after seven factors (scree test), the seven-factor solution is
appropriate [21,22]. For the interpretation of the factor
solution direct oblimin rotation was performed (delta=-Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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Table 2: Descriptive Statistics and scale reliability before and during treatment.
Before treatment During treatment
SCALES Mean score S. D. Cronbach's alpha 
coefficient
Mean score S. D. Cronbach's alpha 
coefficient
P*
AC (activity) 63.44 36.74 0.86 82.71 37.59 0.91 <0.001
SC (self care) 47.29 41.10 0.90 57.93 42.13 0.89 <0.001
HE (health) 57.92 31.30 0.89 68.16 31.93 0.88 <0.001
CT (choice of 
treatment)
48.75 44.42 0.92 51.25 43.34 0.91 0.018
SU (support) 42.50 19.80 0.87 54.72 41.74 0.90 0.007
CO (communication) 74.58 31.01 0.81 79.02 32.03 0.77 0.021
PA (psychological affect) 51.44 36.24 0.92 57.50 41.95 0.83 0.009
* Wilcoxon test.
Table 3: Test retest correlations for all PQLI scales and items.
SCALES Test-retest correlation Items Test-retest correlation
AC (activity) 0.93 Keep working 0.97
House chores 0.89
Enjoyment 0.90
Hobbies 0.94
SC (self care) 0.98 Driving or transportation 0.98
Self care 0.99
HE (health) 0.87 Pain 0.82
Nausea/vomiting 0.98
Lack of appetite 0.76
Weak/tired 0.89
Dyspnoea 0.85
Stool disturbances 0.77
Sleep disturbances 0.98
CT (choice of treatment) 0.96 Like to choose therapeutic schema 0.96
Able to choose therapeutic schema 0.97
SU (support) 0.89 Satisfactory support of relatives/friends 0.95
Satisfactory support of health care team 0.83
Satisfactory support of nursing stuff 0.87
CO (communication) 0.90 Discussion with the doctor on my social 
relationships
0.91
Discussion with the doctor on economic/
professional problems
0.92
Discussion with the doctor on my family problems 0.89
PA (psychological affect) 0.84 Calm 0.73
Optimistic 0.89
Blue 0.84
Control of the situation 0.94
Fears of death 0.74
Overall Quality of life 0.91Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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0.1). The results of the rotation are shown in Table 5. The
variables constituting the seven factors are marked in bold
fonts. By performing an orthogonal rotation using var-
imax, the same 7 factors were identified without any
material difference confirming the results from the non-
orthogonal rotation. Factor 1: Activity (keep working,
house chores, enjoyment, hobbies), factor 2: Self-care
(driving or transportation, self-sufficient), factor 3: Health
Status (pain, nausea/vomiting, lack of appetite, weak/
tired, dyspnoea, stool disturbances, sleep disturbances),
factor 4: Choice of Treatment (Like to choose, able to
choose), factor 5: Support (relatives/friends, health care
team, nursing stuff), factor 6: Communication (social
relationships, economic/professional problems, family
Table 4: Correlations among the PQLI scales.
AC SC HE CT SU CO PA OQOL
Activity (AC) .89a .90a .81a .80a .88a .96a .93a
Self Care (SC) .87a .92a .85a .87a .82a .93a .92a
Health (HE) .89a .90a .95a .80a .63b .96a .90a
Choice of Treatment (CT) .78a .84a .95a .77a .69b .78a .88a
Support (SU) .81a .84a .76a .78a .62b .79a .82a
Communication (CO) .86a .78a .79a .61b .87a .81a .83a
Psychological Affect (PA) .96a .91a .94a .82a .86a .75a .94a
Overall Quality of Life (OQoL) .91a .89a .85a .87a .85a .81a .89a
* Before treatment under the diagonal; during treatment above the diagonal. Values represent the Spearman-rho coefficient. a: correlation is 
significant at the .01 level (2-tailed). b: correlation is significant at the .05 level (2-tailed).
Table 5: Loadings of variables on factors emerging from PQLI rotated factor matrix.
Items Factors
1234567
Keep working 0.93
House chores 0.56 0.43 0.48 0.46
Enjoyment 0.92 0.46
Hobbies 0.93 0.43 0.42
Driving or transportation 0.43 0.54 0.76
Self care 0.93
Pain 0.52 0.69 0.44
Nausea/vomiting 0.41 0.90
Lack of appetite 0.80
Weak/tired 0.56 0.57 0.54
Dyspnoea 0.80
Stool disturbances 0.41 0.72
Sleep disturbances 0.51 0.76
Like to choose therapeutic schema 0.88
Able to choose therapeutic schema 0.95
Satisfactory support of relatives/friends 0.45 0.88
Satisfactory support of health care team 0.91
Satisfactory support of nursing stuff 0.47 0.90
Discussion with the doctor on my social relationships 0.44 0.80
Discussion with the doctor on economic/professional problems 0.47 0.75
Discussion with the doctor on my family problems 0.88
Calm 0.71 0.45
Optimistic 0.45 0.58 0.57 0.56
Blue 0.77 0.43 0.57
Control of the situation 0.44 0.67 0.61 0.41
Fears of death 0.73 0.70Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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Table 6: Correlations between PQLI factors and interview scores for the 120 patients (criterion related validity).
PA CO SU CT HE SC AC
Psychological 
affect (PA)
0.89a 0.58a 0.49a 0.51a 0.45a 0.37b 0.41b
Communication 
(CO)
0.60b 0.75a 0.67a 0.74a 0.38a 0.32b 0.32b
Support (SU) 0.58a 0.61a 0.79a 0.48a 0.41b 0.44b 0.37b
Choice of 
treatment (CT)
0.64a 0.69a 0.77a 0.75a 0.33b 0.52a 0.31b
Health (HE) 0.41b 0.58a 0.62a 0.49a 0.82a 0.58a 0.82a
Self care (SC) 0.53a 0.49a 0.65a 0.38a 0.43b 0.68a 0.64a
Activity (AC) 0.41a 0.37a 0.54b 0.46b 0.74a 0.66a 0.89a
Significant regression paths among latent variables PQLI model predicting interviewing ratings (N = 120). Figure 2
Significant regression paths among latent variables PQLI model predicting interviewing ratings (N = 120). Regression coeffi-
cients are standardized (ap < 0.001, bp < 0.01, cp #60; 0.05)
PA
CO
SU
CT
HE
SC
AC
0.34
c
0.88
a
0.77
a
0.82
a
0.51
b
0.55
b
0.69
b
0.74
a
Interview Instrument
AC
SC
HE
CT
SU
CO
PAHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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problems), and factor 7: Psychological Affect (calm, opti-
mistic, blue, control of the situation, fears of death). The
scale of Overall Quality of Life is not included in any
factor.
Criterion-related validation
As shown in table 3, the correlations under the diagonal
among the scales of PQLI were significantly associated,
giving evidence of concurrent related validity. Following,
the PQLI model was significantly associated with the
empirical model deriving from the patients' interview
(gamma = 0.78, SE = 0.11, p < 0.001). Correlations
between the ratings derived from the interview and the
PQLI factors are reported in Table 6. Interview ratings are
arranged in columns. The highest correlation in each col-
umn coincides with the analogous PQLI latent construct.
We then used the PQLI latent factors as predictors of the
interview ratings. All factors were used as predictors of all
constructs simultaneously. We allowed covariances (cor-
relations) among the predictor variables and significant
covariances among the error residuals of the outcome var-
iables. We gradually dropped paths if they were
nonsignificant until only significant paths remained. The
fit indices for this final path model reflected an excellent
fit (p < 0.001, chi2 test). Results of the predictive model
are reported in Figure 2. We found that the PQLI con-
structs significantly predicted analogous interviewing
scores by the patients. In most cases, there was considera-
ble discriminative validity between similar observed and
reported variables, except that PQLI "health" also pre-
dicted "activity" from the interview rating. To refine these
results, we needed to determine whether the path from
the PQLI "health" factor to the interviewing "health" rat-
ing was significantly larger than the path from PQLI
"health" to the "activity" interviewing rating variable.
Therefore, we ran a model that constrained these paths to
equivalence and then examined the chi2-difference test
between these nested models. The difference test revealed
that the paths were significantly different in magnitude (p
< 0.01), thereby providing additional evidence of the dis-
criminant validity of the PQLI.
Table 7: Correlations between AQEL items and corresponding PQLI items (n = 28).
PQLI AQEL Correlation
Keep working Bodily strength 0.87
House chores
Enjoyment Make you happy 0.79
Hobbies
Driving or transportation -
Self care Help needed with hygiene/dressing 0.72
Pain Pain 0.93
Nausea/vomiting Nausea 0.93
Lack of appetite -
Weak/tired Hours recumbent during day 0.81
Dyspnoea -
Stool disturbances Troubled bowel 0.93
Sleep disturbances Insomnia 0.94
Like to choose therapeutic schema -
Able to choose therapeutic schema -
Satisfactory support of relatives/friends Sharing worries with any member of family 0.55
Regarded as usual by friends 0.75
Satisfactory support of health care team Ability to reach stuff 0.74
Receive appropriate care 0.58
Satisfactory support of nursing stuff Ability to reach stuff 0.44
Receive appropriate care 0.49
Discussion with the doctor on my social relationships -
Discussion with the doctor on economic/professional problems -
Discussion with the doctor on my family problems -
Calm Anxiety 0.85
Optimistic Meaningfulness 0.81
Blue Depression 0.88
Control of the situation -
Fears of death -
Overall QoL Global quality of life 0.79Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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Clinical validity, comparative assessments
Between the PQLI and the Assessment of Quality of Life in
Palliative Care instrument (AQEL) the correlations were,
generally, strong in all the scales, ranging from 0.44 to
0.94. The strongest correlations were found between the
items of "Insomnia" and "Sleep Disturbances" (0.94) and
also in the items of "Pain" (0.93) (Table 7). Moreover,
there were significant correlations between the EORTC
QLQ C30 and the relevant items of PQLI, ranging from
0.79 to 0.97, especially between the items of "Pain"
(0.97), and "Lack of Appetite" (0.97) (table 8). There were
significant correlations between the scales of PQLI and the
relevant scales of AQEL and EORTC QLQ C30, as shown
in table 9. The distinction between patients with low or
high ECOG performance status showed significant rela-
tionship between ECOG scores and instrument scale
scores. As we see in Table 10, patients with a better ECOG
performance status reported significantly higher scores in
all the scales of the instrument.
Discussion
The purpose of this study was to design and evaluate a
method of collecting information about the quality of life
of advanced ill cancer patients receiving palliative care
treatment. Although the primary intent of this project was
to establish the basic reliability and validity of the PQLI
measurement system, we also hoped to demonstrate the
sensitivity to change of this instrument by incorporating it
into a clinical trial using repeated measures design.
The questionnaire was simple to administer and score,
and was well accepted by the responding patients. In aver-
age, it required 8 minutes to complete and, in most cases,
could be filled with little or no assistance. This is a further
Table 8: Correlations between the European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life 
Questionnaire (QLQ-C30, version 3.0) and PQLI items.
PQLI EORTC QLQ-C30 QLQ C30 Item Correlation
Keep working Keep working 6 0.91
House chores Stay in bed or a chair 4 0.83
Enjoyment Interfere with social activities 27 0.79
Hobbies Hobbies 7 0.88
Driving or transportation -
Self care Help with eating, dressing... 5 0.82
Pain Pain 9 0.97
Nausea/vomiting Nausea Vomiting 14 15 0.85 0.89
Lack of appetite Lack of appetite 13 0.97
Weak/tired Weak 12 0.85
Dyspnoea Short of breath 0.92
Diarrhea or Constipation Constipated Diarrhea 16 17 0.91 0.90
Sleep disturbances Trouble sleeping 11 0.95
Like to choose therapeutic schema -
Able to choose therapeutic 
schema
-
Satisfactory support of relatives/
friends
Satisfactory support of health care 
team
Satisfactory support of nursing 
stuff
-
Discussion with the doctor on my 
social relationships
-
Discussion with the doctor on 
economic/professional problems
-
Discussion with the doctor on my 
family problems
-
Calm Tense 21 0.83
Optimistic Worry 22 0.88
Blue Depressed 24 0.90
Control of the situation -
Fears of death -
Overall Q o L Overall Quality of Life 30 0.84Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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proof that the proposed instrument is appropriate for this
patient population, bearing in mind that one of the rea-
sons for developing QoL tools for palliative care is to meet
the needs of patients who cannot use traditional measures
because they are frail and very ill. Patients seemed to be
genuinely pleased that an interest in their quality of life
was a component of their overall care. Two aspects of this
instrument development are worth noting: the opportu-
nity given to the patients to actively participate in this
process, and the incorporation, for the first time, of the
patients' beliefs in their involvement in treatment deci-
sion and what this encompasses. The latter consists a
major advantage of the PQLI over the already existing
ones in Quality of Life.
PQLI showed acceptable to very good reliability and valid-
ity. The internal consistency coefficients for the PQLI sub-
scales are all beyond the acceptable level required for
making group comparisons when evaluating changes in
scores over time. The scales that showed too significant
associations were those of "Activity", "Self-care", and
"Health status". The careful construction of the test deriv-
ing from the patients' interview as well as the setting of
pass/fail scores through the exploratory factor analysis
enhance the content and construct validity of the instru-
ment. The correlation between the latent factors of PQLI
and the empirical factors of patients' interview (Table 6)
provide empirical evidence for concurrent criterion-
related validity. Additionally, the latter was strongly
indicated by the significant regression coefficients as
shown in figure 2. Although the PQLI was related to both
"health" and "activity" item of the interviewing rating
score, this was not unexpected. Indeed, the high
intercorrelation between the "health" and "activity" items
supports the clinical observation that a regressive health
status often occurs in the context/of regressive activity.
Moreover, the significant correlation among the variables
of PQLI indicates that performance is related across test
components as might be expected. Thus the concurrent
related validity had also strong evidence. Furthermore, the
Table 9: Correlations between relevant scales of the PQLI and the scales of AQEL as well as the European Organization for Research 
and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30, version 3.0).
PQLI AQEL Correlation EORTC Correlation
Self-Care _ Physical Functioning (1–5) 0.86
Activity Existential (7, 15, 16) 0.78 Role Functioning (20, 25) 0.83
Psychological Affect Psychological (8–12) 0.91 Emotional Functioning (21–24) 0.80
Health Status Physical (1–6) 0.90 Symptom Scales (8–19) 0.89
Overall Q of Life Global (19) 0.89 Global Quality of Life (29, 30) 0.88
Cognitive (20, 25)
Emotional (21–24)
Social (26, 27)
Financial impact (28)
Choice of Treatment _ _
Support Social (13, 14) _
Communication Medical (17, 18) _
Table 10: Scores by ECOG status, combined validity samples (n = 120).
SCALES ECOG status >2 ECOG status ≤2
Mean score S. D. Mean score S. D. P*
Activity (AC) 51.29 35.04 85.17 29.16 <0.001
Self Care (SC) 37.98 30.17 63.95 41.29 0.001
Health (HE) 52.51 31.41 67.61 29.00 0.011
Choice of Treatment (CT) 42.86 41.89 66.28 40.42 0.004
Support (SU) 45.67 39.41 71.71 40.26 0.001
Communication (CO) 69.05 32.29 84.49 26.07 0.008
Psychological Affect (PA) 47.12 37.62 65.97 37.82 0.009
Overall Quality of Life (OQoL) 48.37 11.11 64.54 11.98 <0.001
* Mann-Whitney U testHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/8
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factor analysis showed that the various components do
assess unique and independent domains, confirming the
discriminative validity of the measures [19].
An important aspect that arises from this study concerns
the doctor-patient communication and the relations of
patients with their families and the important role of the
latter. Concealing a diagnosis of cancer from patients
themselves, unfortunately, is still common practice in
Greece [23]. In "Psychological Affect", and specifically in
the item concerning the "fear of death", 56% of the
patients said that they don't feel fear of death, while
reporting that many have been kept in the dark about the
details of their illness diagnosis and prognosis. While
most Greek doctors nowadays favour disclosing a cancer
diagnosis and prognosis to the patient directly, the rela-
tives often veto this decision, since the role of the family
is very powerful in the Greek culture [24]. Nevertheless,
they reported a high percentage (84.2%) on the item of
support. Regarding the nature of their communication
with their physicians on issues like social relationships,
financial, and family relationships were very low (21.7%,
5.0%, and 12.5% respectively).
Quality of life research can provide the researcher and the
clinician with a clearer view of the impact that a cancer
treatment has on a patient's life. This is clearly shown on
this instrument from the scale that examines the attitude
of patients' toward treatment selection. The responding
patients consider as most important their long-term qual-
ity of life. The participant patients were receiving palliative
treatment, which aims are psychological support and
symptom relief both in short and long term, so the find-
ings are consistent with the nature of the treatment they
are receiving. Moreover, another important aspect that
arises from this study is the participation of the patients in
the treatment choice. Half of the responding population
(50%) reported that they want to choose the treatment
they are going to receive, while a 47.5% said that they
actually do choose their treatment. The latter is quite a
large percentage considering they had no information on
their diagnosis and prognosis.
Conclusions
The psychometric testing of the PQLI provided evidence
that the elements of the measurement appropriately
reflect quality of life in terminal cancer patients since the
tests of validity and reliability yielded consistent results.
Indeed, research initiatives must rely on established
quality of life instruments with proved records of statisti-
cal reliability and validity administered by objective
parties.
These results must be confirmed in larger multicenter tri-
als to decrease any possible selection bias. Moreover,
when conducting a study in quality of life, since it is
subjective in nature, we must remain cautious in our find-
ings, since numbers may be inappropriate to adequately
describe all aspects of patients' lives. Inclusion of health
related quality of life measures in current and future pro-
spective studies would be necessary to provide a database
that is richer and more useful to patients and physicians.
Taken together, these results lend considerable support to
the clinical validity of the PQLI, and could be used as an
audit in clinical studies involving patients with advanced
stage cancer. In future studies we will continue to examine
the validity of quality of life measurements obtained with
the PQLI using a variety of research strategies including
corroboration of additional sources of independent
evidence.
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